The first lawsuit claiming that gastrointestinal drug Zantac causes cancer has been voluntarily dismissed a week before it was due to come to trial, in an early victory for the pharma companies ...

Zantac was originated by GSK and launched by the company in the early 1980s, which sold it as a prescription and over-the-counter (OTC) product for indications like heartburn and acid indigestion ...

Feb 25 (Reuters) - Boehringer Ingelheim has prevailed in the trial of two lawsuits claiming that its discontinued heartburn drug Zantac caused cancer, both of which had previously ended with hung ...

the FDA requested that manufacturers cease selling Zantac and any generic alternatives. Tens of thousands of cancer-stricken patients filed personal injury and product liability lawsuits against ...

GSK claims to investors that its decision to remove Zantac ... of cancer in patients." The Company admitted it could not "quantify or reliably estimate the liability" it would face from lawsuits ...

While the Company repeatedly claimed that scientific research did not support a correlation between Zantac and cancer ... What Is The Lawsuit About? The complaint filed in this class action ...

Smith announces that a class action lawsuit has been filed on behalf ... research did not support a correlation between Zantac and cancer, the Deutsche Bank report stated that the total liability ...

who did not know that GSK had for decades concealed an internal study that implicated GSK's liability to Zantac users. When the true details entered the market, the lawsuit claims that investors ...

GSK claims to investors that its decision to remove Zantac ... of cancer in patients." The Company admitted it could not "quantify or reliably estimate the liability" it would face from lawsuits ...